MD

Pediatrix Medical Group, Inc. - 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 1997. Pediatrix Medical Group, Inc. operates as a provider of neonatal intensive care services. During the nine months ended September 30, 1997, the Company aggressively expanded its footprint, acquiring nine physician group practices and adding three neonatal intensive care units (NICUs) through internal marketing, totaling 29 new NICUs.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net patient service revenue increased 63.4% for the nine months ended September 30, 1997, compared to the prior year. This growth was primarily driven by new units acquired during the period. Same-unit revenue (excluding administrative fees) increased only 1.7%.
• Expense Increases: Salaries and benefits rose 60.7% ($22.4 million increase) due to hiring new physicians for new units and increased support staff. Depreciation and amortization surged 176.2% to $3.1 million, largely due to goodwill amortization from acquisitions.
• Profitability: Net income increased 58.3% to $14.6 million. However, the net income margin decreased slightly from 16.4% to 15.8% due to the impact of goodwill amortization.
• Liquidity: Working capital decreased by $33.6 million to $47.6 million, reflecting significant cash outflows for acquisitions ($52 million paid in the first nine months) offset by operating cash flow.

Guidance, Outlook, Risks, and Contingencies

Outlook and Capital Resources: Management anticipates that funds generated from operations, existing cash, marketable securities, and the credit facility will be sufficient to meet working capital and capital expenditure requirements for the next twelve months. Capital expenditures for the remainder of 1997 are estimated at $500,000.

Subsequent Events: Following the reporting period, the Company acquired one additional physician group practice for approximately $3.5 million. On October 21, 1997, the Company increased its credit facility availability from $30.0 million to $75.0 million.

Risks and Contingencies:

• IRS Examination: The Company is under IRS examination for tax years 1992-1994. The IRS has challenged deductions that could result in additional taxes of approximately $4.5 million plus interest. Management believes the returns are correct and intends to contest the adjustments.
• Contract Dispute: A hospital customer disputes a contract interpretation, seeking a refund of approximately $7.5 million in payments made over five years. Management disagrees with the claim and believes the matter will be resolved amicably or litigated without material adverse effect.
• Legal Proceedings: The Company faces pending medical malpractice claims, which are generally covered by insurance and are not expected to have a material adverse effect.

Investor Verification Checklist

• Verify the sustainability of revenue growth given that same-unit revenue growth was minimal (1.7%) compared to the 63.4% total growth driven by acquisitions.
• Monitor the resolution of the $7.5 million contract dispute with the hospital customer and the $4.5 million potential tax liability from the IRS examination.
• Assess the impact of goodwill amortization on future net income margins as the Company continues its acquisition strategy.
• Review the utilization of the expanded $75.0 million credit facility and the Company's ability to service debt while funding further growth.